Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
BAL30072
print preview
bookmark
share with colleague
General Information
Company
Basilea Pharmaceutica AG
Description
Siderophore sulfactam antibiotic
Molecular Target
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Gram-negative bacterial infection
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy